Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Fantastic, TTTav66
Your Report:
Anavex Life Sciences and Ariana Pharma present positive phase II clinical and biomarker data at the AD/PD 2022 International Conference
Pushing the promise of AI designed Precision Medicine Parkinson’s Disease Dementia (PDD) therapy closer to the finish line, Ariana, the AI Drug Development Company and ANAVEX Life Sciences announced positive ANAVEX®2-73 Phase II results.
“The reported strong positive biomarker and clinical results in Parkinson’s Disease Dementia, building on previously reported positive results in RETT syndrome and Alzheimer’s disease, further illustrate the power of KEM® Explainable AI to accelerate precision medicine drug development building on in-depth understanding of the intersection between SIGMAR1 molecular pathways and disease biology” said Mohammad Afshar, M.D., Ph.D., Chief Executive Officer of Ariana Pharma.
https://www.arianapharma.com/anavex-ad-pd-2022-international-conference/
'tradeherpete - Yes. I believe AVXL has met all of their end points in all of their drug trials in the CNS space to date. That would make DR. Missling NUMERO UNO CNS BIOTECH CEO. YES. IMO
Power - Well said. RETT, PDD, AD the shoe fits. A2-73 WINNER!
Lets dance!
https://www.bing.com/videos/search?q=david+bowie+lets+dance+yutube&view=detail&mid=ACA4548AFB4A40E70951ACA4548AFB4A40E70951&FORM=VIRE
Great post, Steady_T. Also. Bottom line is that AVXL has met every CNS drug trial end points to date, unlike other CNS drug pharmaceutical companies.
AVXL - Leader in the CNS biotech space.
Best
7 in 10 long COVID patients still battle memory and concentration problems.
A2-73 to the rescue!
https://www.studyfinds.org/long-covid-memory-problems/
H.C. Wainwright Thinks Anavex Life Sciences’ Stock is Going to Recover
Consensus of Strong Buy. $42.00 Price Target!
H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Anavex Life Sciences (AVXL – Research Report) today and set a price target of $42.00. The company’s shares closed last Tuesday at $10.65, close to its 52-week low of $9.28.
According to TipRanks.com, Selvaraju has currently 0 stars on a ranking scale of 0-5 stars, with an average return of -33.9% and a 17.3% success rate. Selvaraju covers the Healthcare sector, focusing on stocks such as Reviva Pharmaceuticals Holdings, Aquestive Therapeutics, and Vallon Pharmaceuticals.
https://www.tipranks.com/news/blurbs/h-c-wainwright-thinks-anavex-life-sciences-stock-is-going-to-recover?utm_source=advfn.com&utm_medium=referral
Todays news release should have raised our market cap $1 billion dollars. With our current drug trial results we should have a $3 to 5 billion MC in the CNS space. imo.
It looks like market manipulation and needs to be re evaluated. imo
https://finance.yahoo.com/news/anavex-life-sciences-highlights-biomarker-160450172.html
Dr. Jaime Kulisevsky, MD, PhD, Principal Investigator of the trial, commented, "PDD is a debilitating disorder with significant co-morbidities and there has not been a mechanistically novel medication approved for PDD in over 20 years. Hence, new therapies are urgently needed to alleviate this suffering and disability. I am impressed with the robust improvement of the MDS-UPDRS across all sub-score parts I-IV coupled with the biomarker correlated outcome measures and I support the implementation of the ANAVEX®2-73 Phase 3 studies in Parkinson's disease and Parkinson's disease dementia, respectively.
Right on, georgejjl. AVXL Leader in the CNS Biotech Space.
"A very interesting patent application for the treatment of inflammation.
Search the patent for Anavex".
19. The composition of claim 18, wherein the S1R agonist is selected from the group consisting of PRS-013, SA-4503, siramesine, (+)-pentazocine, (+)-SKF10,047, PRE084 (2-morpholin-4-ylethyl 1-phenylcyclohexane-1-carboxylate), SA4503 (1-4-(3-phenylpropyl)piperazine), (.+-.)-PPCC oxalate, PRE-084 hydrochloride, SA 4503 dihydrochloride, (+)-SK&F 10047 hydrochloride, and a compound commercially available under the following trade names ANAVEX.RTM. 2-73, ANAVEX.RTM. 3-71, ANAVEX.RTM. 1-51, ANAVEX.RTM. 1079, ANAVEX.RTM. 1067, ANAVEX.RTM. 1037, ANAVEX.RTM. 1519, and ANAVEX.RTM. 1066.
https://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PG01&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.html&r=1&f=G&l=50&s1=%2220220023291%22.PGNR.&OS=DN/20220023291&RS=DN/20220023291
https://video.search.yahoo.com/search/video?fr=mcafee&ei=UTF-8&p=marshawn+lynch+beast+mode&type=E211US105G0#id=2&vid=ece268fd988c36202212cbe4291ff288&action=click
Great post, basparks79. Most people would never think that our system could get so corrupt. Best
Really. Looks like a pattern to me. imo
All imo. "File lawsuit against Adam Feuerstein for stock manipulating and injecting false statements against CYTR and NVAX to drive the stock prices down for his personal gain. Adam Feuerstein should be held responsible for his action and pay for the damage he caused".
https://secure.avaaz.org/community_petitions/en/Steven_A_Kriegsman_File_lawsuit_against_Adam_Feuerstein_for_stock_manipulation/#:~:text=File%20lawsuit%20against%20Adam%20Feuerstein%20for%20stock%20manipulating,action%20and%20pay%20for%20the%20damage%20he%20caused
What. Does he have a cousin?
Just FYI. I does happen. imo
https://www.sec.gov/litigation/litreleases/2021/lr25167.htm
Agree. They have been stealing money here for years. imo
Agree 100%. Bull Shit.
Your comment:
Insulin doesn't "cure" diabetes, either. But those with either form of the disease won't quibble over therapeutic terminology. "Wait. I'm gonna stop taking my insulin. It fails; doesn't cure my diabetes."
"Blarcamesine for my daughter with Rett, or my grandmother with Alzheimer's? Nope. Can't have that new drug. Doesn't cure either disease. An abject failure. Won't stand (or pay) for it."
Good one, falconer66a. Great explanation and spot on.
I thank God for his higher love. Please give us A2-73. Many thanks.
https://video.search.yahoo.com/search/video?fr=mcafee&ei=UTF-8&p=bring+me+a+higher+love&type=E211US105G0#id=3&vid=e5bbc8c42c2a176bcb12ba2b1281065d&action=view
Your quote:
"Your sarcasm is not that far from some peoples truth. There are very powerful circles of people in control that actually believe this…..at least for “other” old people".
Right, tredenwater2. That's also the "Rules for thee, but not for me" crowd.
Hey Bourbon. Time for a little Beast Mode action here. C-mon.
https://video.search.yahoo.com/search/video?fr=mcafee&ei=UTF-8&p=marshawn+lynch+beast+mode&type=E211US105G0#id=1&vid=ece268fd988c36202212cbe4291ff288&action=click
Bourbon. Might be best to run it in. Just sayin.
I thank God for a higher love. Please give us A2-73. Many thanks.
https://video.search.yahoo.com/search/video?fr=mcafee&ei=UTF-8&p=bring+me+a+higher+love&type=E211US105G0#id=3&vid=e5bbc8c42c2a176bcb12ba2b1281065d&action=view
A little Friday Night ET.
Eric Clapton and Steve Winwood -
Nice Xena. Both are good but I like the 1969 version better.
People , getting ready for the news.. And the crowd is growing bigger. All the time.. Band of Brothers
It's called, people quietly stealing your money. imo.
More than likely Spot On!
AVXL is part of the Nasdaq stealth crash stocks. Down 60% + or -. imo
Perfect analogy. If Missling shares to much information his enemy's know to much. Best to just drive for approval and establish a revenue.
A-V-X-L Leader in the CNS Biotech space.
ANAVEX®2-73 (Blarcamesine) AVATAR Phase 3 Trial met Primary and Secondary Efficacy Endpoints for the Treatment of Adult Patients with Rett Syndrome.
https://finance.yahoo.com/news/anavex-2-73-blarcamesine-avatar-120000337.html
Kentucky123 - Your a lot smarter than that. AVXL is the leader in the CNS biotech space. Current drug trial results are better than the current SOC drugs available in the CNS space.. And get this. Very little to no side effects.
Sign me up for A2-73 via~ home delivery. C-mon.
JWC3' I agree. We should be $124.90 right now with current drug trial data results. imo
AVXL - Long Train Running..A2-73 Best in Class and WINNER in the CNS Biotech Space imo. C-Mon
Great find, 'DFRAI.
Talkin bout china grove! in vevo - Best to all AVXL - WINNER!!!
AVXL-2-73 Leader in the CNS Biotech space.
AA-VVXXLL = WINNER!!! C-Mon
Sorry and Best to you, Steady_T'.
Great Saturday night music for a CNS WINNER!
Long Train Running..
Time to have some fun and listen to the music.
AVXL- Leader in the CNS Biotech space.